In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery…
Read More
Fiasp (Novo Nordisk) is a faster insulin aspart with an earlier onset of action. In contrast to NovoLog, which is recommended to be dosed within 5-10 minutes before…
Read More
In response to findings of a safety signal report that there is reasonable suspicion of a causal association between use of Increlex® and childhood neoplasia, including malignancy,…
Read More
The FDA has approved two new ready to use forms of glucagon and these have been introduced to the market: an intranasal powder (Baqsimi, Eli Lilly)…
Read More